317 related articles for article (PubMed ID: 16199867)
1. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
[TBL] [Abstract][Full Text] [Related]
3. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
[TBL] [Abstract][Full Text] [Related]
4. RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells.
Jian Y; Gao Z; Sun J; Shen Q; Feng F; Jing Y; Yang C
Oncogene; 2009 Nov; 28(47):4201-11. PubMed ID: 19734942
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.
Li J; Zhang X; Sejas DP; Pang Q
Leuk Res; 2005 Dec; 29(12):1415-23. PubMed ID: 15964625
[TBL] [Abstract][Full Text] [Related]
6. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
[TBL] [Abstract][Full Text] [Related]
7. p53-Dependent and -independent functions of the Arf tumor suppressor.
Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
[TBL] [Abstract][Full Text] [Related]
8. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53.
Moulin S; Llanos S; Kim SH; Peters G
Oncogene; 2008 Apr; 27(17):2382-9. PubMed ID: 17968318
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
Tago K; Chiocca S; Sherr CJ
Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
[TBL] [Abstract][Full Text] [Related]
10. Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype.
King D; Yang G; Thompson MA; Hiebert SW
Oncogene; 2002 Jul; 21(32):4978-82. PubMed ID: 12118376
[TBL] [Abstract][Full Text] [Related]
11. Role of nucleophosmin in embryonic development and tumorigenesis.
Grisendi S; Bernardi R; Rossi M; Cheng K; Khandker L; Manova K; Pandolfi PP
Nature; 2005 Sep; 437(7055):147-53. PubMed ID: 16007073
[TBL] [Abstract][Full Text] [Related]
12. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis.
Yuan X; Zhou Y; Casanova E; Chai M; Kiss E; Gröne HJ; Schütz G; Grummt I
Mol Cell; 2005 Jul; 19(1):77-87. PubMed ID: 15989966
[TBL] [Abstract][Full Text] [Related]
13. Nucleophosmin regulates the stability and transcriptional activity of p53.
Colombo E; Marine JC; Danovi D; Falini B; Pelicci PG
Nat Cell Biol; 2002 Jul; 4(7):529-33. PubMed ID: 12080348
[TBL] [Abstract][Full Text] [Related]
14. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
Brady SN; Yu Y; Maggi LB; Weber JD
Mol Cell Biol; 2004 Nov; 24(21):9327-38. PubMed ID: 15485902
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of v-Abl transformation by p53 and p19ARF.
Cong F; Zou X; Hinrichs K; Calame K; Goff SP
Oncogene; 1999 Dec; 18(54):7731-9. PubMed ID: 10618713
[TBL] [Abstract][Full Text] [Related]
16. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.
Bertwistle D; Sugimoto M; Sherr CJ
Mol Cell Biol; 2004 Feb; 24(3):985-96. PubMed ID: 14729947
[TBL] [Abstract][Full Text] [Related]
17. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence.
Cheng K; Grisendi S; Clohessy JG; Majid S; Bernardi R; Sportoletti P; Pandolfi PP
Oncogene; 2007 Nov; 26(53):7391-400. PubMed ID: 17546053
[TBL] [Abstract][Full Text] [Related]
18. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
Eischen CM; Alt JR; Wang P
Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19 Arf network.
Castelli M; Pieroni S; Brunacci C; Piobbico D; Bartoli D; Bellet MM; Colombo E; Pelicci PG; Della Fazia MA; Servillo G
Oncogene; 2013 Jul; 32(28):3350-8. PubMed ID: 22890319
[TBL] [Abstract][Full Text] [Related]
20. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.
Sharpless NE; Bardeesy N; Lee KH; Carrasco D; Castrillon DH; Aguirre AJ; Wu EA; Horner JW; DePinho RA
Nature; 2001 Sep; 413(6851):86-91. PubMed ID: 11544531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
